Market Tracker

07/03 4:45pm ET

Nektar Therapeutics (NASDAQ:NKTR)

11.89
Delayed Data
As of Jul 02
 -0.23 / -1.90%
Today’s Change
9.51
Today|||52-Week Range
17.53
-23.29%
Year-to-Date

Today’s Trading

Previous close12.12
Today’s open12.12
Day’s range11.78 - 12.21
Volume1,231,658
Average volume (3 months)1,973,672
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-26.19%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+34.77%
P/E ratio59.2
Price/Sales9.80
Price/Book42.94

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...-0.18-2.22%
FGENFibroGen Inc-0.21-0.90%
DBVTDBV Technologies SA+0.11+0.36%
KERXKeryx Biopharmaceuti...-0.17-1.73%
Data as of 3:59pm ET, 07/02/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts